Rehab program shows promise for scleroderma Patients' daily life

NCT ID NCT00318188

Completed Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a personalized rehabilitation program could improve quality of life for people with systemic sclerosis, a disease that causes skin and joint stiffness. 220 adults with the condition were randomly assigned to either the rehab program or usual care. The program focused on exercises and activities to reduce disability and improve daily function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: personalized standardized rehabilitation program
What this could lead to: If successful, this could offer a non-drug way to improve daily function and quality of life for people with systemic sclerosis.
What could go wrong: This is a completed trial, but rehabilitation effects can vary widely. The program may not work for everyone, and results depend on patient adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLERODERMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse scleroderma systemic sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC SCLERODERMA

Contacts and locations

Locations

Reeducation and readaptation Department

Paris, 75679, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.